Literature DB >> 20698773

The efficacy of human placenta as a source of the universal feeder in human and mouse pluripotent stem cell culture.

Yong Park1, Seung Jin Lee, In Young Choi, Se Ryeon Lee, Hwa Jung Sung, Jong Hoon Kim, Young Do Yoo, Dong Ho Geum, Sun Haeng Kim, Byung Soo Kim.   

Abstract

The use of a mouse embryonic fibroblast (MEF) feeder for culture of embryonic stem cells (ESCs) is a widely accepted method, regardless of the ESCs' origin and type. In this study, we performed the undifferentiated propagation of human ES cell lines (hESCs, H1, and HSF6) and mouse ES cell lines (mESCs, D3, and CE3), which were previously maintained on an MEF feeder, using human placenta-derived fibroblast-like cell (HPC) feeders originated from chorionic villi of women who had undergone therapeutic abortion due to known maternal disease that is aggravated by pregnancy. Moreover, we tried to introduce the HPC feeder for the establishment of inducible pluripotent stem cells (iPSCs) from human placental mesenchymal stem cells (MSCs). On the HPC feeder we were able to propagate ESCs and iPSCs colonies as an undifferentiated state up to the 50th passage and 20th passage, respectively. Maintenance of undifferentiated ESCs was identified by the expression of ALP, SSEA-1, SSEA-4, TRA-81, TRA-60, Oct-4, Nanog, or Rex-1. Also, addition of leukemia inhibitory factor was not required for undifferentiated propagation of mESCs on the HPC feeder. The efficiency and expression of three germ layer markers of embryoid bodies (EBs) from ESCs were satisfactory in both the MEF and HPC group. EBs formed from iPSCs were scant, and differentiation to the three germ layers was identifiable by reverst transcription-polymerase chain reactio (RT-PCR) only in the HPC group. In conclusion, the HPC feeder can efficiently support the undifferentiated propagation of hESCs, mESCs, and iPSCs, suggesting that human placenta may be a useful source of universal feeder cells for hESC, mESC, and iPSC culture.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20698773     DOI: 10.1089/cell.2009.0113

Source DB:  PubMed          Journal:  Cell Reprogram        ISSN: 2152-4971            Impact factor:   1.987


  6 in total

1.  CXCR2 and its related ligands play a novel role in supporting the pluripotency and proliferation of human pluripotent stem cells.

Authors:  Ji-Hye Jung; Seung Jin Lee; JiHea Kim; SongHee Lee; Hwa-Jung Sung; Jungsuk An; Yong Park; Byung Soo Kim
Journal:  Stem Cells Dev       Date:  2014-12-23       Impact factor: 3.272

2.  A Novel Culture Model for Human Pluripotent Stem Cell Propagation on Gelatin in Placenta-conditioned Media.

Authors:  Ji-Hye Jung; Byung Soo Kim
Journal:  J Vis Exp       Date:  2015-08-03       Impact factor: 1.355

3.  Human Wharton's jelly-derived mesenchymal stem cells express oocyte developmental genes during co-culture with placental cells.

Authors:  Hamid Reza Asgari; Mohammad Akbari; Mehdi Abbasi; Jafar Ai; Morteza Korouji; Fereshte Aliakbari; Kehinde Adebayo Babatunde; Fereydoon Sargolzaei Aval; Mohammad Taghi Joghataei
Journal:  Iran J Basic Med Sci       Date:  2015-01       Impact factor: 2.699

4.  hESC expansion and stemness are independent of connexin forty-three-mediated intercellular communication between hESCs and hASC feeder cells.

Authors:  Jin-Su Kim; Daekee Kwon; Seung-Taeh Hwang; Dong Ryul Lee; Sung Han Shim; Hee-Chun Kim; Hansoo Park; Won Kim; Myung-Kwan Han; Soo-Hong Lee
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

5.  Enhanced Reprogramming Efficiency and Kinetics of Induced Pluripotent Stem Cells Derived from Human Duchenne Muscular Dystrophy.

Authors:  Pooja Teotia; Sujata Mohanty; Madhulika Kabra; Sheffali Gulati; Balram Airan
Journal:  PLoS Curr       Date:  2015-09-03

6.  CXCR2 Inhibition in Human Pluripotent Stem Cells Induces Predominant Differentiation to Mesoderm and Endoderm Through Repression of mTOR, β-Catenin, and hTERT Activities.

Authors:  Ji-Hye Jung; Ka-Won Kang; Jihea Kim; Soon-Chul Hong; Yong Park; Byung Soo Kim
Journal:  Stem Cells Dev       Date:  2016-07-01       Impact factor: 3.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.